Objective: To determine 1) airway outcome of infants with laryngomalacia who do not
undergo routine direct laryngoscopy (DL) and bronchoscopy (B), 2) the age at resolution of …

Objective To medically and audiologically characterize a population of children diagnosed as
having auditory neuropathy (AN). Study Design Retrospective medical chart review. Setting…

Objective To describe and to determine the robustness of our study evaluating the efficacy
of OK-432 (Picibanil) as a therapeutic modality for lymphangiomas. Design and Setting …

Objective/Hypothesis: The prevalence and causes of pediatric hearing loss (HL) in the
developing world are largely unknown. Infectious sequelae, ototoxic medications, and genetic …

Sensorineural hearing loss (SNHL) is the most common sensory deficit in humans, occurring
in 2 to 4 per 1000 live births and affecting an estimated 40,000 children in the United States …

Objective To report the benefits and complications of subcutaneous interferon alfa-2a therapy
for hemangiomas in children. Design Prospective nonrandomized trial. Setting Tertiary …

METHODS Subjects A total of 164 Caucasian subjects, who were younger than 19 years
and had been diagnosed with non-syndromic sensorineural hearing impairment at the …

Purpose: The aim of the study was to determine the actual GJB2 and GJB6 mutation
frequencies in North America after several years of generalized testing for autosomal recessive …

OBJECTIVE: Our objective was to determine the diagnostic yield of laboratory testing,
radiological imaging, and GJB2 mutation screening in a large cohort of patients with differing …

Picibanil (OK-432) is a sclerosing agent derived from a low-virulence strain of Streptococcus
pyogenes that induces regression of macrocystic lymphangiomas. This report describes a …